About The Study: This study found an association between glucagonlike peptide-1 receptor agonist (GLP-1RA) use and a lower risk of acute asthma exacerbations in adolescents with overweight or obesity. The findings suggest a potential dual benefit for this population, where a single class of medication could address both weight management and lower risk for asthma exacerbation, thereby potentially reducing the burden of 2 common and interconnected chronic conditions.
Corresponding Authors: To contact the corresponding authors, email Lin-Shien Fu, MD, ( linshienfu@gmail.com ) and Tim C. C. Lin, PhD, ( chichenlin1@gmail.com ).
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.51611)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.51611?guestAccessKey=1b34668e-afe8-4888-aa3d-dd05b3b83eff&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122925
JAMA Network Open